Featured Clinical Leader Editorial
-
In Clinical Research, Every Day Is Groundhog Day
1/30/2025
Rather than proffer some New Year's predictions, Paul Ivsin looks at clinical research through the lens of Groundhog Day and the tradition of reinventing the same thing over and over again.
-
How AI Will Transform Health Equity In Clinical Trials In 2025
12/23/2024
Click Therapeutics' CMO/CSO Shaheen Lakhan, MD, Ph.D., FAAN explains how the shift toward AI is the first step in addressing diversity in clinical trials.
-
Siteless DCTs Are Real … And Happening Now
6/20/2024
Siteless DCTs (decentralized trials) are rare, but Praxis Precision Medicines is running one now for patients with essential tremor (ET). Marcio Souza, PharmD, the company’s president and CEO, talks about why they chose this model and the surprising speed at which it is progressing.
-
Will Today's Clinical Trial Trends Become Tomorrow's Routine?
4/23/2024
Clinical trial trends can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in therapeutic areas. Will these trends hold steady as 2024 unfolds?
-
Post-Pandemic Planning: Using Direct-To-Patient Deliveries For Supply Chain Management
2/23/2024
UCB Vice President – Head of Global Clinical Science and Operations Tero Laulajainen gets us up to speed on direct-to-patient (DTP) trials and how UCB is leveraging it today.
-
4 Things I Learned At SCOPE 2024
2/21/2024
The Summit for Clinical Ops Executives (SCOPE) ran from Feb. 11-4. Discover four things Executive Editor Abby Proch learned at the annual event.
-
Ramblings From A First-Time SCOPE Attendee
2/15/2024
Dan Schell, chief editor of Clinical Leader, discusses what sessions stood out to him and some of the KOLs he rubbed elbows with while attending his first SCOPE Summit.
-
4 Things I'm Looking Forward To At SCOPE 2024
2/1/2024
The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.
-
3 Ways Biotechs Can Lower The Cost Of Clinical Trials
1/23/2024
LongeVC has identified three innovative models to help biotechs lower the cost of their clinical trials.
-
Clinical Trial Diversity, Flexibility Championed By The Food And Drug Omnibus Reform Act
5/23/2023
The Food and Drug Omnibus Reform Act, signed into law by President Biden on Dec. 29, 2022, includes provisions intended to modernize clinical trials and are broadly divided into two categories: encouraging the enrollment of diverse populations and facilitating novel clinical trial designs.